Gene Query: DMKN

Dataset Description Geneva Score
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 85.56
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 80.1
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 79.18
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 52.87
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 51.8
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 50.07
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 43.46
Dermal endothelial cells of type 2 diabetic patients 38.84
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 37.93
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 37.92
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 37.85
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 37.85
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  37.79
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 37.52
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 36.28
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 35.8
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 35.64
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 35.28
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 34.27
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 33.56
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 33.48
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 33.44
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 33.34
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 31.58
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 31.54
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 31.54
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 30.86
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 30.86
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 30.78
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 30.78
Effect of BMP inhibition or stimulation of primary human keratinocytes 30.78
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 30.18
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 29.9
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 28.76
MCF10A H-Ras RNA-Seq 28.5
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 28.43
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 28.42
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 28.42
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 27.49
HEK293 TFAM Knockout Expression Study 27.04
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 26.93
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 26.93
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 26.82
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 26.45
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 26.45
RNA sequencing analysis of human embryonic stem cells and axial progenitors 26.27
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 26.24
The Genomic Landscape of Atypical Fibroxanthoma 25.98
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 25.54
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 25.36
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 24.88
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 24.88
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 24.42
Global transcriptome analysis of HAP1 cells 24.15
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 23.96
Differetially expressed genes after hTR overexpression in U2OS cells 23.75
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 22.77
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 22.77
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 22.4
Transcriptome profiling of Normal and Cancerous Prostate Cells 21.97
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 21.73
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 21.72
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 21.54
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 21.47
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 21.35
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 21.35
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 21.2
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 21.01
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 20.86
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 20.55
RNA-seq of human aneuploid cell lines with Trisomy 21 20.39
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 19.91
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 19.9
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 19.83
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 19.8
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 19.8
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 19.72
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 19.64
Mechanistic Model-Guided Study of Embryonic Morphogenesis 19.07
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 19.06
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 18.91
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 18.88
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 18.7
Depicting early human development and germ cell origin with porcine embryos 18.53
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 18.11
Expression profiling of converted and control dermal BJ fibroblasts 18.11
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 18.06
NR2F2 study 18.06
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 17.87
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 17.8
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 17.74
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 17.6
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 17.46
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 17.45
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 17.28
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 17.28
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 17.2
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 17.2
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 17.07
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 16.73
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 16.73
Transcriptome analysis of virus infected tissues 16.65
Transcriptome analysis of H9 hESC derived cerebral organoids 16.53
Generation of KRAS signatures using immortalized isogenic lung cells. 16.45
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 16.43
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 16.41
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 16.41
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 16.34
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 16.22
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 16.12
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 15.89
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 15.89
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 15.8
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 15.77
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 15.69
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 15.69
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 15.43
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 15.19
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 15.18
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 15.18
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 15.07
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 15.05
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 15.03
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 14.98
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 14.71
A549 cells and MSR-A549 cells 14.71
Fbxo32 mediated gene expression program underlies EMT and metastasis 14.69
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 14.63
FOXD3 is a novel tumor suppressor in lung cancer 14.56
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 14.53
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 14.47
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 14.47
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 14.42
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 14.35
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 14.17
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 14.17
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 14.13
Lineage specific differentiation is influenced by state of human pluripotency 14.13
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 14.03
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 14.01
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 14.0
Global analysis of alternative splicing regulated by RBM10 13.92
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 13.79
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 13.76
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 13.71
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 13.71
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 13.66
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 13.64
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 13.49
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 13.49
Differentially expressed vascular development genes for iPSC-ECs from CDI 13.45
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 13.45
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 13.41
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 13.36
Total RNA sequencing of WT intestinal orgaonids. 13.27
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 13.13
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 12.99
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 12.92
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 12.91
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 12.9
Rorc disruption in human FG pancreatic cancer cells 12.84
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 12.8
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 12.73
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 12.71
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 12.71
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 12.59
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 12.5
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 12.37
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 12.37
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 12.26
Lipid degradation promotes prostate cancer cell survival 11.97
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 11.75
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 11.75
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 11.69
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 11.46
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 11.43
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 11.26
RNA-seq of MCF10A cells and CAF 11.25
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 11.25
High-efficiency RNA-based reprogramming of human primary fibroblasts 11.25
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 11.23
TCF7L1 knockdown in pancreatic cancer 11.21
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 11.2
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 11.19
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 11.15
RNA expression following TMPRSS11B overexpression or depletion 11.01
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 10.99
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 10.95
Patient-derived luminal breast cancer xenografts with progestins 10.88
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 10.88
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 10.81
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 10.81
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 10.74
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 10.74
RNA-seq of naive and primed ES cells 10.74
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 10.68
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 10.57
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 10.57
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 10.57
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 10.42
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 10.35
Transcriptome analysis of kidney organoids 10.29
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 10.26
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 10.22
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 10.19
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 10.17
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 10.05
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 9.99
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 9.93
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 9.86
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 9.83
RNA-sequencing of formalin fixed human primary melanoma tissue 9.83
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 9.8
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 9.78
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 9.78
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 9.71
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 9.71
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 9.7
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 9.66
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 9.6
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 9.54
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 9.54
A transcriptome dataset revealing the molecular features of breast cancer stem cells 9.54
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 9.51
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.5
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 9.46
NHLRC1 re-expression in cancer cells 9.46
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 9.45
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 9.45
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 9.38
Control of prostate tumour growth by the long non-coding RNA GHSROS 9.34
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 9.31
CHD1 regulates cell fate determination by activation of differentiation-induced genes 9.26
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 9.24
ETV7 and interferon response 9.24
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 9.23
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 9.23
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 9.1
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 9.01
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 8.99
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 8.99
RNA-seq of young and quiescent MRC-5 human fibroblasts 8.97
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 8.94
miR941 overexpression experiment 8.87
Examining serotonergic neuron differentiation from human iPSCs 8.85
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 8.84
Paxillin regulates genomic networks in prostate cancer [PC3] 8.83
G-quadruplex structures mark human regulatory chromatin 8.79
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 8.73
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 8.65
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 8.65
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 8.64
Cerebellar differentiation in Ataxia-Telangiectasia 8.62
Crizotinib v. DMSO in SW480 cells 8.5
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 8.49
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 8.46
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.45
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 8.43
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 8.43
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 8.42
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 8.42
HEK293 Heat-shock experiment 8.32
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 8.31
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 8.25
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 8.25
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 8.23
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 8.18
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 8.15
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 8.15
A prostate cancer chromatin interaction map 8.1
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 7.96
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 7.95
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 7.95
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 7.92
Biological effect of chronic mistranslation in mammalian cells 7.9
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 7.86
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 7.86
hTERT promotes cell adhesion and migration independent of telomerase activity 7.81
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 7.68
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 7.68
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 7.68
Gene Expression Profiling of SPOP Knocked Down Cell 7.55
Next Generation Sequencing of human SMA and healthy control Motor Neurons 7.54
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 7.53
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 7.5
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 7.5
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 7.5
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 7.47
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 7.47
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 7.46
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 7.44
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 7.32
RNA-sequencing in immortalized human mammary epithelial cells 7.32
RNA seq comparison between scrambled and shGRP78 cells 7.3
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 7.29
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 7.26
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 7.23
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 7.22
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 7.08
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 7.04
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.04
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 7.03
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 7.03
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 7.01
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 7.01
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 7.0
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 6.91
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 6.89
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 6.86
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 6.83
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 6.83
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 6.82
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 6.8
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 6.78
Ro60-knockout cells 6.75
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 6.73
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 6.73
Gene expression profiling of human and murine in vitro muscle differentiation 6.7
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 6.7
RNA-seq analysis of RALD iPSCs after in vitro differentiation 6.61
PRDM1 inhibits proliferation of human colon cancer organoids 6.53
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 6.49
ARID1A and ARID1B loss in HCT116 cells 6.31
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 6.28
iPSC-Derived Cholangiocytes 6.28
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 6.26
Engineering Patient-Specific Tissue Implants 6.17
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 6.15
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 6.12
Endometrial transcriptome and PGR cistrome in cycling fertile women 6.12
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 6.12
Active translatome profiling with RiboLace in MCF7 cells 6.09
FGF2 regulation of gene expression in stable inducible Neurons 6.06
Regulatory network controlling tumor-promoting inflammation in human cancers 6.05
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 6.05
Epigenome regulation during epidermal lineage commitment 5.98
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 5.94
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 5.9
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 5.9
Chromatin landscape of human visceral and subcutaneous adipocytes 5.87
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 5.86
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 5.81
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 5.81
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 5.8
AMPK signaling for naïve pluripotency 5.75
AMPK signaling for naïve pluripotency [Hs] 5.75
MCF-7 as a model for functional analysis of breast cancer risk variants 5.69
Single cell transcriptome of peritoneal cells 5.66
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 5.66
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 5.49
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 5.45
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 5.44
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 5.38
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 5.28
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 5.2
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 5.2
Dissecting neural differentiation regulatory networks through epigenetic footprinting 5.19
RNAseq analysis of ruxolitinib treated breast cancers 5.16
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 5.04
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 4.96
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 4.91
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 4.91
Derivation and differentiation of haploid human embryonic stem cells 4.9
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 4.88
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 4.86
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 4.77
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 4.73
RNA-Seq analysis of human colorectal cancer with liver metastasis 4.69
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 4.67
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 4.63
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 4.63
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 4.57
Gene expression and genome-wide location analysis of breast cancer cell-lines 4.56
Gene expression analysis of breast cancer cell-lines 4.56
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 4.54
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 4.54
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 4.49
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 4.47
RNA sequencing of human mammary epithelial cells 4.46
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 4.45
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 4.45
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 4.38
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 4.35
RNAseq of cell lines with knocked in ESR1 mutations 4.35
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 4.29
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 4.27
Investigate A2M treatment on human prostate cancer xenograft in mice 4.23
Investigate A2M treatment on human prostate cancer and mouse liver 4.23
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 4.22
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 4.19
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 4.05
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 4.03
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 4.01
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 4.01
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 3.98
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.97
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 3.78
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 3.78
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 3.76
Molecular Criteria for Defining the Naive Human Pluripotent State 3.73
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.7
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 3.67
CSL RNA-Seq on HKC and SCC cell lines 3.6
CSL 3.6
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 3.49
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 3.46
RNA-Seq of Breast and Ovarian Cancer Cell Lines 3.46
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 3.41
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 3.39
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 3.39
Knockdown of ADNP in HCT116 colon cancer cells 3.39
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 3.35
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 3.28
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 3.28
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 3.19
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.99
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 2.93
Finding missing proteins from epigenetically manipulated human cells 2.92
The cohesin release factor WAPL restricts chromatin loop extension. 2.88
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.88
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 2.8
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 2.74
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 2.71
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 2.71
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.66
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 2.66
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 2.64
JAK dependent survival of ALK- ALCL 2.62
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.55
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 2.53
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 2.46
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 2.45
BMS-470539 on human synovial fibroblasts 2.44
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 2.43
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 2.35
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 2.27
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 2.08
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 2.08
Gene expression profiling in metabolically heterogeneous human lung tumors 2.07
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 2.03
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.0
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.0
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 1.99
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 1.98
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 1.98
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.94
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.94
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.92
ARID1A and ARID1B loss in HCT116 and TOV21G cells 1.9
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 1.83
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 1.76
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 1.75
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.64
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 1.61
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.52
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.47
Effect of ILF3 on translation during homeostasis and the antiviral response 1.39
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.33
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.33
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 1.28
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.28
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 1.25
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 1.25
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 1.25
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.2
Identification of the role of polydom in neurofibromas 1.18
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.16
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.1
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.1
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.1
Hepatic transcriptome of pediatric hepatoblastoma. 0.97
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.93
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.9
RNAseq of Breast cancer PDX samples 0.85
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.84
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.71
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.67
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.64
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.52
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.47
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 0.46
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.44
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.38
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.36
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.35
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.35
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.33
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.33
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.32
mRNA sequencing of oropharyngeal cancer cell lines 0.31
Ribosomal protein RPL26 is the principal target of UFMylation 0.28
Downregulation of LATS kinases alters p53 to promote cell migration 0.26
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.21
Identification of expressed and conserved human non-coding RNAs 0.2
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 0.16
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.13
A single cell reference map for human blood and tissue T cell activation 0.1
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 0.06
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.04
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation